The utility of the MMPI-3 in predicting substance use related problems in a clinical neuropsychology sample.

Autor: Maccarone KJ; Department of Psychological Sciences, Kent State University, Kent, OH, USA., Barni EE; Department of Psychological Sciences, Kent State University, Kent, OH, USA., Ben-Porath YS; Department of Psychological Sciences, Kent State University, Kent, OH, USA.
Jazyk: angličtina
Zdroj: Applied neuropsychology. Adult [Appl Neuropsychol Adult] 2023 Jul 15, pp. 1-11. Date of Electronic Publication: 2023 Jul 15.
DOI: 10.1080/23279095.2023.2235451
Abstrakt: Assessing for problematic substance use in neuropsychological assessments is crucial for differential diagnosis and attribution of symptom causes. The current investigation examines the utility of the Minnesota Multiphasic Personality Inventory-3 (MMPI-3 in predicting such substance use in a clinical neuropsychology sample. Participants included 208 outpatient neuropsychological examinees. Correlations and risk ratios were calculated for externalizing-psychopathology-related scales and external substance use criteria. Hierarchical regressions examined the incremental prediction of criteria by MMPI-3 externalizing scales above the Substance Abuse (SUB) scale. Results indicate that MMPI-3 externalizing scales are associated with substance-use-related criteria as conceptually expected. Additionally, we report significantly increased risk of experiencing substance-use-related problems at various T score elevations on multiple externalizing scales. Finally, SUB served as the primary predictor of substance-use-related criteria. These findings support the ability of the MMPI-3 to assess for past or current substance use and negative consequences of substance use in a clinical neuropsychology setting.
Databáze: MEDLINE